You have 9 free searches left this month | for more free features.

City

Hackensack (1)

Melbourne (1)

Condition

Stroke (3)

Stroke Sequelae (2)

Stroke, Cardiovascular (2)

Stroke, Cryptogenic (2)

Stroke, Embolic (2)

Stroke, Ischemic (2)

Strokes Thrombotic (2)

GVHD (1)

Overall Status

Not yet recruiting (2)

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Moleac Pte Ltd. (3)

Hackensack Meridian Health (1)

Collaborator

Moleac Australia Pty Ltd (1)

Intervention

mlc1501 (3)

placebo (2)

cyp cocktail (1)

telmisartan (1)

transporter cocktail (1)

Study Documents

Intervention Type

drug (4)

other (2)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

MLC1501

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Stroke, Stroke, Ischemic, Strokes Thrombotic Trial (Placebo, MLC1501)

Not yet recruiting

Stroke
+6 more

Placebo
MLC1501

(no location specified)

Mar 11, 2022

Stroke, Stroke, Ischemic, Strokes Thrombotic Trial (MLC1501, Placebo)

Not yet recruiting

Stroke
+6 more

MLC1501
Placebo

(no location specified)

Mar 10, 2022

Stroke Trial in Melbourne (MLC1501, CYP Cocktail, Transporter Cocktail)

Completed

Stroke

MLC1501
+2 more

Melbourne, Victoria, Australia

Nucleus Network

Sep 1, 2020

GVHD Trial in Hackensack (Telmisartan)

Active, not recruiting

GVHD

Telmisartan

Hackensack, New Jersey

Hackensack University Medical Center

Sep 2, 2022